Newer Horizon of Mesenchymal Stem Cell-Based Therapy in the Management of SARS-CoV-2-Associated Mucormycosis: A Safe Hope for Future Medicine.

Front Microbiol · 2021 · PMC8543035 · PMID 34707590

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

an increasing trendno p-value reported

Recently, mucormycosis is showing an increasing trend due to several reasons associated with COVID-19, including comorbidities such as DM, DKA, prolonged steroid treatment, that hamper SARS-CoV-2-infected host immunity and provide an opportunity for Mucorales to inhabit the host.

also in 63,971 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.